Clinical practice guidelines within the Southern African Development Community: a descriptive study of the quality of guideline development and concordance with best evidence for five priority diseases.
BACKGROUND
Reducing the burden of disease relies on availability of evidence-based clinical practice guidelines (CPGs). There is limited data on availability, quality and content of guidelines within the Southern African Development Community (SADC). This evaluation aims to address this gap in knowledge and provide recommendations for regional guideline development.


METHODS
We prioritised five diseases: HIV in adults, malaria in children and adults, pre-eclampsia, diarrhoea in children and hypertension in primary care. A comprehensive electronic search to locate guidelines was conducted between June and October 2010 and augmented with email contact with SADC Ministries of Health. Independent reviewers used the AGREE II tool to score six quality domains reporting the guideline development process. Alignment of the evidence-base of the guidelines was evaluated by comparing their content with key recommendations from accepted reference guidelines, identified with a content expert, and percentage scores were calculated.


RESULTS
We identified 30 guidelines from 13 countries, publication dates ranging from 2003-2010. Overall the 'scope and purpose' and 'clarity and presentation' domains of the AGREE II instrument scored highest, median 58%(range 19-92) and 83%(range 17-100) respectively. 'Stakeholder involvement' followed with median 39%(range 6-75). 'Applicability', 'rigour of development' and 'editorial independence' scored poorly, all below 25%. Alignment with evidence was variable across member states, the lowest scores occurring in older guidelines or where the guideline being evaluated was part of broader primary healthcare CPG rather than a disease-specific guideline.


CONCLUSIONS
This review identified quality gaps and variable alignment with best evidence in available guidelines within SADC for five priority diseases. Future guideline development processes within SADC should better adhere to global reporting norms requiring broader consultation of stakeholders and transparency of process. A regional guideline support committee could harness local capacity to support context appropriate guideline development.
South African Cochrane Centre, South African Medical Research Council, Cape Town, Western Cape, South Africa. Tamara.kredo@mrc.ac.za
Tamara
T
Kredo
Annette
A
Gerritsen
Johan
J
van Heerden
Shaun
S
Conway
Nandi
N
Siegfried
D000163:Acquired Immunodeficiency Syndrome / Q000628:therapy; D000328:Adult; D000353:Africa, Southern; D002648:Child; D003967:Diarrhea / Q000628:therapy; D005069:Evaluation Studies as Topic; D019317:Evidence-Based Medicine / Q000592:standards*; D005260:Female; D015658:HIV Infections / Q000628:therapy; D006801:Humans; D006973:Hypertension / Q000628:therapy; D008288:Malaria / Q000628:therapy; D008297:Male; D017410:Practice Guidelines as Topic; D011225:Pre-Eclampsia / Q000628:therapy; D011247:Pregnancy; D011786:Quality Control